Identification of a therapeutic strategy targeting amplified FGF19 in liver cancer by oncogenomic screening

We screened 124 genes that are amplified in human HCC using a mouse hepatoblast model and identified 18 tumor-promoting genes, including CCND1 and its neighbor on 11q13.3, FGF19. Although it is widely assumed that CCND1 is the main driving oncogene of this common amplicon (15% frequency in HCC), bot...

Description complète

Enregistré dans:
Détails bibliographiques
Auteurs principaux: Sawey, Eric T., Chanrion, Maia, Cai, Chunlin, Wu, Guanming, Zhang, Jianping, Zender, Lars, Zhao, Alice, Busuttil, Ronald W., Yee, Herman, Stein, Lincoln, French, Dorothy M., Finn, Richard S., Lowe, Scott W., Powers, Scott
Format: Artigo
Langue:Inglês
Publié: 2011
Sujets:
Article
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC3061399/
https://ncbi.nlm.nih.gov/pubmed/21397858
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.ccr.2011.01.040
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires